{
    "id": "36357344-6528-ef04-e063-6394a90a8fa9",
    "indications": {
        "text": "mupirocin ointment indicated topical treatment impetigo due susceptible isolates staphylococcus aureus ( s. aureus ) streptococcus pyogenes ( s. pyogenes ) .",
        "doid_entities": [
            {
                "text": "impetigo (DOID:8504)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8504"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "topical . apply small amount mupirocin ointment , cotton swab gauze pad , affected area 3 times daily 10 days . cover treated area gauze dressing desired . re-evaluate patients showing response within 3 5 days . mupirocin ointment intranasal , ophthalmic , mucosal [ ( 5.2 , 5.6 ) ] . apply mupirocin ointment concurrently lotions , creams , ointments [ pharmacology ( 12.3 ) ] .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "gram mupirocin ointment usp 2 % contains 20 mg mupirocin water-miscible ointment base . mupirocin ointment usp , 2 % supplied follows : ndc 81033-032-01 : 1-gram tube ndc 81033-032-50 : box 50 ( 1-gram tubes ) ndc 81033-032-99 : box 100 ( 1-gram tubes ) store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "mupirocin ointment contraindicated patients known hypersensitivity mupirocin excipients mupirocin ointment .",
    "ingredients": [
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "MUPIROCIN",
            "code": "D0GX863OA5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7025"
        }
    ],
    "organization": "Kesin Pharma Corporation",
    "name": "Mupirocin",
    "effectiveTime": "20250528",
    "indications_original": "Mupirocin ointment is indicated for the topical treatment of impetigo due to susceptible isolates of \n  Staphylococcus aureus (S. aureus) and \n  Streptococcus pyogenes (S. pyogenes).",
    "contraindications_original": "For Topical Use Only.\n                     Apply a small amount of mupirocin ointment, with a cotton swab or gauze pad, to the affected area 3 times daily for up to 10 days.\n                     Cover the treated area with gauze dressing if desired.\n                     Re-evaluate patients not showing a clinical response within 3 to 5 days.\n                     Mupirocin ointment is not for intranasal, ophthalmic, or other mucosal use \n   [see Warnings and Precautions (5.2, 5.6)] .\n  \n                     Do not apply mupirocin ointment concurrently with any other lotions, creams, or ointments \n   [see Clinical Pharmacology (12.3)].",
    "warningsAndPrecautions_original": "Each gram of Mupirocin Ointment USP 2% contains 20 mg mupirocin in a water-miscible ointment base.\n                  Mupirocin Ointment USP, 2% is supplied as follows:\n                  NDC 81033-032-01: 1-gram tube\n                  NDC 81033-032-50: Box of 50 (1-gram tubes)\n                  NDC 81033-032-99: Box of 100 (1-gram tubes)\n                  \n                  Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Mupirocin ointment is contraindicated in patients with known hypersensitivity to mupirocin or any of the excipients of mupirocin ointment.",
    "drug": [
        {
            "name": "Mupirocin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7025"
        }
    ]
}